Package 71288-168-50

Brand: cytarabine

Generic: cytarabine
NDC Package

Package Facts

Identity

Package NDC 71288-168-50
Digits Only 7128816850
Product NDC 71288-168
Product ID 71288-168_038a9b4b-a951-4c8c-be74-00a4a64eedd1
Description

1 VIAL, MULTI-DOSE in 1 CARTON (71288-168-50) / 50 mL in 1 VIAL, MULTI-DOSE

Marketing

Marketing Status
Marketed Since 2017-11-09
Brand cytarabine
Generic cytarabine
Sample Package No

Linked Drug Pages (1)

Cytarabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "038a9b4b-a951-4c8c-be74-00a4a64eedd1", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["240416"], "spl_set_id": ["1be2668b-d76f-4c65-aea9-86c5c40889a2"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Meitheal Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (71288-168-50)  / 50 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "71288-168-50", "marketing_start_date": "20171109"}], "brand_name": "Cytarabine", "product_id": "71288-168_038a9b4b-a951-4c8c-be74-00a4a64eedd1", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "71288-168", "generic_name": "Cytarabine", "labeler_name": "Meitheal Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "20 mg/mL"}], "application_number": "ANDA206190", "marketing_category": "ANDA", "marketing_start_date": "20171109", "listing_expiration_date": "20261231"}